CAR-T Meeting 2023 | How changes in the gut microbiome may impact patient response to CAR-T therapy
Marco Ruella
• 9 Feb 2023
Marco Ruella, MD, University of Pennsylvania, Philadelphia, PA, shares some insights into a study which evaluated the impact of the gut microbiome on patient response to CAR-T therapy. Results from this study demonstrated that exposure to certain antibiotics prior to CAR-T cell infusion may result in a poorer outcome, and Dr Ruella highlights the need for more research in this space. This interview took place at the EBMT-EHA 5th European CAR T-cell Meeting held in Rotterdam, The Netherlands.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
